Advertisement
OtherMinireview

THE PHARMACOLOGICAL CASE FOR CANNABIGEROL (CBG)

Rahul Nachnani, Wesley M Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics November 9, 2020, JPET-MR-2020-000340; DOI: https://doi.org/10.1124/jpet.120.000340

Article Information

JPET-MR-2020-000340
DOI 
https://doi.org/10.1124/jpet.120.000340
PubMed 
33168643
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online November 9, 2020.
Copyright & Usage 

Author Information

  1. Rahul Nachnani1,
  2. Wesley M Raup-Konsavage1, and
  3. Kent E. Vrana2,*
  1. 1Pharmacology, Penn State College of Medicine, United States of America
  2. 2Dept. of Pharmacology, Penn State College of Medicine, United States
  1. ↵* Corresponding Author:
    Kent E. Vrana, Dept. of Pharmacology, Penn State College of Medicine, Penn State College of Medicine, 500 University Dr, Hershey, Pennsylvania, 17033-0850, United States. E-mail: kvrana{at}psu.edu

Statistics from Altmetric.com

Article usage

Article usage: November 2020 to January 2021

AbstractFullPdf
Nov 20203790265
Dec 20202810168
Jan 20211690108

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
OtherMinireview

Potential Clinical Uses of CBG

Rahul Nachnani, Wesley M Raup-Konsavage and Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics November 9, 2020, JPET-MR-2020-000340; DOI: https://doi.org/10.1124/jpet.120.000340
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section